Zhejiang Medicine Co Ltd (600216) — Cash Flow Reinvestment Rate
Zhejiang Medicine Co Ltd (600216) has a Cash Flow Reinvestment Rate of 0.12x as of September 2025, reinvesting CN¥80.03 Million (capex CN¥80.03 Million ) from operating cash flow of CN¥690.77 Million. Check 600216 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Medicine Co Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Zhejiang Medicine Co Ltd across 27 annual periods. Explore 600216 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year capital reinvestment analysis for Zhejiang Medicine Co Ltd. For live market cap and broader valuation context, see 600216 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | CN¥453.57 Million | CN¥1.89 Billion | CN¥446.47 Million | ▼ -58.8% |
| 2024 | 0.58x | CN¥714.46 Million | CN¥1.22 Billion | CN¥689.14 Million | ▼ -71.8% |
| 2023 | 2.07x | CN¥1.32 Billion | CN¥634.31 Million | CN¥796.87 Million | ▼ -44.6% |
| 2022 | 3.74x | CN¥1.95 Billion | CN¥520.60 Million | CN¥975.99 Million | ▲ +334.4% |
| 2021 | 0.86x | CN¥978.73 Million | CN¥1.14 Billion | CN¥939.60 Million | ▲ +29.5% |
| 2020 | 0.66x | CN¥835.67 Million | CN¥1.26 Billion | CN¥535.35 Million | ▼ -52.8% |
| 2019 | 1.41x | CN¥630.40 Million | CN¥447.25 Million | CN¥573.63 Million | ▲ +79.9% |
| 2018 | 0.78x | CN¥454.26 Million | CN¥579.91 Million | CN¥439.30 Million | ▼ -53.7% |
| 2017 | 1.69x | CN¥851.21 Million | CN¥503.47 Million | CN¥569.99 Million | ▲ +48.8% |
| 2016 | 1.14x | CN¥382.01 Million | CN¥336.14 Million | CN¥381.76 Million | ▼ -87.8% |
| 2015 | 9.29x | CN¥989.93 Million | CN¥106.54 Million | CN¥724.96 Million | ▲ +415.2% |
| 2014 | 1.80x | CN¥991.76 Million | CN¥549.90 Million | CN¥991.76 Million | ▼ -0.5% |
| 2013 | 1.81x | CN¥1.19 Billion | CN¥655.09 Million | CN¥1.19 Billion | ▲ +54.8% |
| 2012 | 1.17x | CN¥945.50 Million | CN¥807.49 Million | CN¥945.50 Million | ▲ +210.2% |
| 2011 | 0.38x | CN¥344.58 Million | CN¥912.75 Million | CN¥344.58 Million | ▲ +240.6% |
| 2010 | 0.11x | CN¥145.90 Million | CN¥1.32 Billion | CN¥145.90 Million | ▲ +6.0% |
| 2009 | 0.10x | CN¥153.13 Million | CN¥1.47 Billion | CN¥153.13 Million | ▼ -3.7% |
| 2008 | 0.11x | CN¥130.27 Million | CN¥1.20 Billion | CN¥130.27 Million | ▼ -83.9% |
| 2007 | 0.67x | CN¥153.37 Million | CN¥227.67 Million | CN¥153.37 Million | ▼ -54.3% |
| 2006 | 1.47x | CN¥249.99 Million | CN¥169.51 Million | CN¥249.99 Million | ▼ -89.2% |
| 2005 | 13.60x | CN¥341.93 Million | CN¥25.14 Million | CN¥341.93 Million | ▲ +910.5% |
| 2004 | 1.35x | CN¥144.80 Million | CN¥107.60 Million | CN¥144.80 Million | ▼ -32.2% |
| 2003 | 1.98x | CN¥131.37 Million | CN¥66.20 Million | CN¥131.37 Million | ▼ -78.5% |
| 2002 | 9.25x | CN¥213.81 Million | CN¥23.13 Million | CN¥213.81 Million | ▲ +654.2% |
| 2001 | 1.23x | CN¥120.44 Million | CN¥98.25 Million | CN¥120.44 Million | ▼ -89.5% |
| 2000 | 11.69x | CN¥123.69 Million | CN¥10.58 Million | CN¥123.69 Million | ▲ +435.0% |
| 1998 | 2.18x | CN¥126.08 Million | CN¥57.72 Million | CN¥126.08 Million | — |